Tribunnews Reporter, Fitri Wulandari
TRIBUNNEWS.COM, BRUSSELS – European Union (EU) will sign an agreement with the manufacturer of the monkeypox vaccine (Monkeypox) on Tuesday local time for the supply of around 110,000 doses.
EU Health Commissioner Stella Kyriakides said that the name of the vaccine manufacturer is still being kept secret, but that hundreds of thousands of these vaccines will be delivered by the end of June 2022.
Quoted from the abc.net.au page, Tuesday (14/6/2022), on the sidelines of a meeting of EU Health Ministers in Luxembourg this Tuesday, Kyriakides said the vaccine would be purchased using EU funds and sent to member countries.
The commission official later said that the name of the vaccine manufacturer would be announced soon.
Earlier, the EU drug regulator said that as of this month, it was in talks with Danish biotech company ‘Bavarian Nordic’ on trial data that could support the extension of the use of the approved Imvanex injection.
In the United States (US), the vaccine is known as Jynneos.
Read also: WHO Finalizes Guidelines on Procedures for Handling Monkeypox Patients
US regulators have also approved the Bavarian Nordic smallpox vaccine for use against Monkeypox.
Several countries in the EU, including Germany and Spain, have already made their own orders for the vaccine.
Kyriakides said that the EU had recorded 900 cases of Monkeypox.
To date, Monkeypox has been making headlines as it spreads through unconventional means.
The World Health Organization (WHO) has said that an outbreak of Monkeypox outside Africa would not cause a pandemic.
But the agency is now considering whether the outbreak should be assessed as a ‘potential public health emergency of international concern’.
–
